Esperion Therapeutics, Inc. (ESPR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1153837,
"name": "Esperion Therapeutics, Inc.",
"stock_name": "Esperion Therapeutics, Inc.",
"full_name": "Esperion Therapeutics, Inc.",
"name_url": "stocks-analysis/esperion-therapeutics-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "3.79",
"chg": 0.13,
"chgp": "3.55%",
"dir": 1,
"prev_price": "3.66",
"mcapval": "511.08",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2305,
"indexname": "S&P 500",
"isin": "US29664W1053",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "9.46 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-register-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/esperion-therapeutics-inc-1153837-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Esperion Therapeutics Experiences Evaluation Revision Amidst Mixed Market Indicators and Performance Trends",
"link": "https://www.marketsmojo.com/news/stocks-in-action/esperion-therapeutics-technical-trend-changes-from-bullish-to-mildly-bullish-amid-price-decline-3600981",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EsperionTherape_technicaldot_3600981.png",
"date": "2025-10-07 19:39:28",
"description": "Esperion Therapeutics, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, priced at $3.12, has shown significant volatility over the past year. While it has outperformed the S&P 500 in shorter time frames, longer-term performance reveals a decline compared to the broader market."
},
{
"title": "Is Esperion Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-technically-bullish-or-bearish-3599029",
"imagepath": "",
"date": "2025-10-07 12:16:32",
"description": "As of 3 October 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a bullish MACD on the weekly chart and a bullish daily moving average. However, the weekly RSI indicates bearish momentum, while the monthly KST shows a bearish signal. The Bollinger Bands are mildly bullish on the weekly and bullish on the monthly, and Dow Theory reflects a mildly bullish stance across both time frames. Overall, the mixed signals suggest a cautious bullish outlook. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Esperion Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-technically-bullish-or-bearish-3593757",
"imagepath": "",
"date": "2025-10-06 12:06:39",
"description": "As of 3 October 2025, the technical trend for Esperion Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. However, the weekly RSI is bearish, suggesting potential weakness in the short term. The Bollinger Bands are bullish on both weekly and monthly time frames, supporting the mildly bullish stance. Moving averages are bullish on the daily chart, which adds to the positive outlook. Dow Theory indicates a mildly bullish trend on both weekly and monthly scales. Overall, the indicators present a mixed picture, leaning towards a mildly bullish stance. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Esperion Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-technically-bullish-or-bearish-3591829",
"imagepath": "",
"date": "2025-10-05 11:51:37",
"description": "As of 3 October 2025, the technical trend for Esperion Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The weekly RSI is bearish, indicating some weakness, but the Bollinger Bands are bullish for both weekly and monthly time frames. Daily moving averages are bullish, supporting a positive short-term outlook. The Dow Theory shows a mildly bullish stance on both weekly and monthly levels. However, the KST is bullish weekly but bearish monthly, and the OBV is mildly bearish weekly with no trend monthly.\n\nIn terms of performance, Esperion has outperformed the S&P 500 significantly over the past week (24.53% vs. 1.09%) and month (35.80% vs. 4.15%), but it has underperformed over longer periods such as the 3-year and 5-year returns. Overall, the current technical stance is mildly bullish, driven by strong short-term indicators de..."
},
{
"title": "Is Esperion Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-technically-bullish-or-bearish-3558366",
"imagepath": "",
"date": "2025-09-23 11:19:48",
"description": "As of 19 September 2025, the technical trend for Esperion Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish weekly but bearish monthly. The Dow Theory reflects a mildly bullish trend in both weekly and monthly perspectives. \n\nIn terms of performance, the stock has returned 15.67% over the past month compared to the S&P 500's 3.95%, and it has a strong 49.40% return over the past year against the S&P 500's 16.64%. However, the long-term performance shows significant underperformance over 3 and 5 years. Overall, the current technical stance is bullish with moderate strength...."
},
{
"title": "Is Esperion Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-technically-bullish-or-bearish-3552216",
"imagepath": "",
"date": "2025-09-22 18:06:02",
"description": "As of 19 September 2025, the technical trend for Esperion Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and a bullish signal from Bollinger Bands on the monthly timeframe. The KST is bullish weekly but bearish monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly charts. \n\nIn terms of performance, the stock has returned 30.39% over the past month compared to 3.95% for the S&P 500, and it has a 1-year return of 52.00% versus 16.64% for the benchmark. However, the longer-term returns over 3 years and 5 years show significant underperformance relative to the S&P 500...."
},
{
"title": "Is Esperion Therapeutics, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-technically-bullish-or-bearish-3545821",
"imagepath": "",
"date": "2025-09-20 19:19:25",
"description": "As of 8 September 2025, the technical trend for Esperion Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including a bullish MACD on the weekly timeframe, bullish daily moving averages, and mildly bullish Bollinger Bands on the monthly timeframe. However, the weekly RSI is bearish, indicating some short-term weakness. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past month with a return of 30.95% compared to the S&P 500's 2.33%, and over the past year with a return of 58.05% versus 17.14%...."
},
{
"title": "Is Esperion Therapeutics, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-esperion-therapeutics-inc-overvalued-or-undervalued-3542492",
"imagepath": "",
"date": "2025-09-20 17:54:03",
"description": "As of 8 May 2019, the valuation grade for Esperion Therapeutics, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company is considered overvalued given its negative P/E ratio, a price to book value of -0.57, and an EV to EBITDA ratio of -18.10. In comparison, Protalix Biotherapeutics, Inc. has a P/E of 20.08, highlighting a stark contrast in valuation metrics among peers.\n\nDespite a notable 1-month stock return of 30.95%, which outperformed the S&P 500's 2.33% return, the long-term performance is concerning, with a 5-year return of -92.98% compared to the S&P 500's 96.61%. This suggests that while there may be short-term gains, the overall outlook for Esperion remains bleak, reinforcing the conclusion that the stock is overvalued...."
}
],
"total": 13,
"sid": "1153837",
"stock_news_url": "https://www.marketsmojo.com/news/esperion-therapeutics-inc-1153837"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Esperion Therapeutics Experiences Evaluation Revision Amidst Mixed Market Indicators and Performance Trends

2025-10-07 19:39:28

Esperion Therapeutics, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, priced at $3.12, has shown significant volatility over the past year. While it has outperformed the S&P 500 in shorter time frames, longer-term performance reveals a decline compared to the broader market.

Is Esperion Therapeutics, Inc. technically bullish or bearish?

2025-10-07 12:16:32

As of 3 October 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a bullish MACD on the weekly chart and a bullish daily moving average. However, the weekly RSI indicates bearish momentum, while the monthly KST shows a bearish signal. The Bollinger Bands are mildly bullish on the weekly and bullish on the monthly, and Dow Theory reflects a mildly bullish stance across both time frames. Overall, the mixed signals suggest a cautious bullish outlook. Multi-period return data is not available for comparison with the S&P 500....

Is Esperion Therapeutics, Inc. technically bullish or bearish?

2025-10-06 12:06:39

As of 3 October 2025, the technical trend for Esperion Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. However, the weekly RSI is bearish, suggesting potential weakness in the short term. The Bollinger Bands are bullish on both weekly and monthly time frames, supporting the mildly bullish stance. Moving averages are bullish on the daily chart, which adds to the positive outlook. Dow Theory indicates a mildly bullish trend on both weekly and monthly scales. Overall, the indicators present a mixed picture, leaning towards a mildly bullish stance. Multi-period return data is not available for comparison with the S&P 500....

Is Esperion Therapeutics, Inc. technically bullish or bearish?

2025-10-05 11:51:37

As of 3 October 2025, the technical trend for Esperion Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The weekly RSI is bearish, indicating some weakness, but the Bollinger Bands are bullish for both weekly and monthly time frames. Daily moving averages are bullish, supporting a positive short-term outlook. The Dow Theory shows a mildly bullish stance on both weekly and monthly levels. However, the KST is bullish weekly but bearish monthly, and the OBV is mildly bearish weekly with no trend monthly. In terms of performance, Esperion has outperformed the S&P 500 significantly over the past week (24.53% vs. 1.09%) and month (35.80% vs. 4.15%), but it has underperformed over longer periods such as the 3-year and 5-year returns. Overall, the current technical stance is mildly bullish, driven by strong short-term indicators de...

Is Esperion Therapeutics, Inc. technically bullish or bearish?

2025-09-23 11:19:48

As of 19 September 2025, the technical trend for Esperion Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish weekly but bearish monthly. The Dow Theory reflects a mildly bullish trend in both weekly and monthly perspectives. In terms of performance, the stock has returned 15.67% over the past month compared to the S&P 500's 3.95%, and it has a strong 49.40% return over the past year against the S&P 500's 16.64%. However, the long-term performance shows significant underperformance over 3 and 5 years. Overall, the current technical stance is bullish with moderate strength....

Is Esperion Therapeutics, Inc. technically bullish or bearish?

2025-09-22 18:06:02

As of 19 September 2025, the technical trend for Esperion Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and a bullish signal from Bollinger Bands on the monthly timeframe. The KST is bullish weekly but bearish monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly charts. In terms of performance, the stock has returned 30.39% over the past month compared to 3.95% for the S&P 500, and it has a 1-year return of 52.00% versus 16.64% for the benchmark. However, the longer-term returns over 3 years and 5 years show significant underperformance relative to the S&P 500....

Is Esperion Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:19:25

As of 8 September 2025, the technical trend for Esperion Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including a bullish MACD on the weekly timeframe, bullish daily moving averages, and mildly bullish Bollinger Bands on the monthly timeframe. However, the weekly RSI is bearish, indicating some short-term weakness. In terms of performance, the stock has outperformed the S&P 500 over the past month with a return of 30.95% compared to the S&P 500's 2.33%, and over the past year with a return of 58.05% versus 17.14%....

Is Esperion Therapeutics, Inc. overvalued or undervalued?

2025-09-20 17:54:03

As of 8 May 2019, the valuation grade for Esperion Therapeutics, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company is considered overvalued given its negative P/E ratio, a price to book value of -0.57, and an EV to EBITDA ratio of -18.10. In comparison, Protalix Biotherapeutics, Inc. has a P/E of 20.08, highlighting a stark contrast in valuation metrics among peers. Despite a notable 1-month stock return of 30.95%, which outperformed the S&P 500's 2.33% return, the long-term performance is concerning, with a 5-year return of -92.98% compared to the S&P 500's 96.61%. This suggests that while there may be short-term gains, the overall outlook for Esperion remains bleak, reinforcing the conclusion that the stock is overvalued....

View All News